Trial Profile
Evaluation of BOL-303242-X Versus Vehicle for the Treatment of Inflammation Following Cataract Surgery
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Sep 2020
Price :
$35
*
At a glance
- Drugs Mapracorat (Primary)
- Indications Postoperative inflammation
- Focus Therapeutic Use
- Sponsors Bausch & Lomb
- 23 Dec 2014 New trial record